Directory
>
Peter Prieto Md Mph Cmq Facs Fsso
Peter Prieto Md Mph Cmq Facs Fsso
Senior Vice President, Medical Affairs | Iovance Biotherapeutics, Inc.
City of Rochester, New York, United States
Peter Prieto Md Mph Cmq Facs Fsso
Summary
Dr. Peter Prieto is a renowned melanoma surgical oncologist and immunotherapist, currently serving as the Senior Vice President of Medical Affairs at Iovance Biotherapeutics. With a strong background in critical care and surgical oncology, he is also an adjunct clinical professor at the University of Rochester Medical Center. His career is marked by a commitment to patient advocacy and safety, alongside significant contributions to clinical research in immunotherapy and surgical techniques. Dr. Prieto has founded his own medical practice, showcasing his entrepreneurial spirit. He has authored several influential publications in top-tier medical journals, highlighting his expertise in melanoma treatment and immunotherapy. His work emphasizes the importance of combining innovative therapies to improve patient outcomes. Dr. Prieto's dedication to advancing cancer treatment is evident through his leadership roles and ongoing research efforts.
Peter Prieto Md Mph Cmq Facs Fsso
Work Experience
Senior Vice President, Medical Affairs at
Iovance Biotherapeutics, Inc.
May 2023 - Present
Adjunct Clinical Professor, Surgical Oncology at
University of Rochester
May 2023 - Present
Founder & CEO at
Prieto Medical LLC
August 2021 - Present
Consultant at
Castle Biosciences, Inc.
January 2021 - Present
Associate Program Director of Research, General Surgery at
University of Rochester
July 2018 - Present
Assistant Professor of Surgical Oncology at
University of Rochester
August 2017 - May 2023
Director of Research, Surgical Residency Program at
University of Rochester
July 2018 - May 2023
Fellow, Complex General Surgical Oncology at
The University of Texas M D Anderson Cancer Center
July 2014 - June 2017
Chief Resident, General Surgery at
Yale University Press
July 2013 - June 2014
Senior Resident, General Surgery at
Yale University Press
July 2011 - June 2013
Clinical Fellow, Immunotherapy & Surgical Oncology at
National Cancer Institute (NCI)
July 2008 - June 2011
Assistant Resident, General Surgery at
Upstate Medical Anesthesiology Group, Inc.
July 2007 - June 2008
Intern, General Surgery at
Upstate Medical Anesthesiology Group, Inc.
July 2006 - June 2007
Peter Prieto Md Mph Cmq Facs Fsso
Education
Frequently Asked Questions about Peter Prieto Md Mph Cmq Facs Fsso
What is Peter Prieto Md Mph Cmq Facs Fsso email address?
Peter Prieto Md Mph Cmq Facs Fsso's primary email address is ************@iovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Peter Prieto Md Mph Cmq Facs Fsso work for?
Peter Prieto Md Mph Cmq Facs Fsso is a Senior Vice President, Medical Affairs at Iovance Biotherapeutics, Inc., a company specializing in Commercial physical research.
Where Peter Prieto Md Mph Cmq Facs Fsso graduated from?
Peter Prieto Md Mph Cmq Facs Fsso holds a degree in from Stony Brook University.
How can I directly contact Peter Prieto Md Mph Cmq Facs Fsso?
To contact Peter Prieto Md Mph Cmq Facs Fsso directly, you can use the email address ************@iovance.com. Complete contact information is available upon registration with Muraena.
Who is Peter Prieto Md Mph Cmq Facs Fsso?
Dr. Peter Prieto is a renowned melanoma surgical oncologist and immunotherapist, currently serving as the Senior Vice President of Medical Affairs at Iovance Biotherapeutics. With a strong background in critical care and surgical oncology, he is also an adjunct clinical professor at the University of Rochester Medical Center. His career is marked by a commitment to patient advocacy and safety, alongside significant contributions to clinical research in immunotherapy and surgical techniques. Dr. Prieto has founded his own medical practice, showcasing his entrepreneurial spirit. He has authored several influential publications in top-tier medical journals, highlighting his expertise in melanoma treatment and immunotherapy. His work emphasizes the importance of combining innovative therapies to improve patient outcomes. Dr. Prieto's dedication to advancing cancer treatment is evident through his leadership roles and ongoing research efforts.
Peter`s contact details
************@iovance.com
Colleagues
Executive Director, Clinical Development, Oncology
Vice President, Cell Therapy Account Teams
Vice President, Research Alliances
Interim CEO and General Counsel
Chief Medical Officer
Executive Director
SVP Head of Digital and Information Technology
Vice President, Regulatory Affairs
Executive Director, CMC Biostatistics
VP, Global Commercial Operations